Back to search

Belgium· BE-AMP-SAM661416-00

Radelumin 1300 MBq/ml

A psma-1007 18f product containing (3s,10s,14s)-1-[4-[[(2s)-4-carboxy-2-[(2s)-4-carboxy-2-(6-[18f]fluoropyridin-3-amido)butanamido]butanamido]methyl]phenyl]-3-[(naphthalen-2-yl)methyl]-1,4,12-trioxo-2,5,11,13-tetraazahexadecane-10,14,16-tricarboxylic acid, registered in Belgium by Abx Advanced Biochemical Compounds - Biomedizinische Forschungsreagenzien. The same ATC class is registered in 4 of our 19 countries.

ATC V09IX17

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedRadelumin 1300 MBq/mlATCV09IX17REGISTER NO.BE-AMP-SAM661416-00PACKS LISTED0CHECKEDSeptember 26, 2026

Where it is registered

Psma-1007 18f is registered in 4 of 19 countries.

Countries holding a registration under ATC V09IX17 (psma-1007 18f), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 3 of them publish a price we can compare per daily dose

Psma-1007 18f · ATC V09IX17

4 / 19 countries

  • Belgiumprice
  • Netherlands
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
(3S,10S,14S)-1-[4-[[(2S)-4-carboxy-2-[(2S)-4-carboxy-2-(6-[18F]fluoropyridin-3-amido)butanamido]butanamido]methyl]phenyl]-3-[(naphthalen-2-yl)methyl]-1,4,12-trioxo-2,5,11,13-tetraazahexadecane-10,14,16-tricarboxylic acid
Manufacturer
Abx Advanced Biochemical Compounds - Biomedizinische Forschungsreagenzien
Country
Belgium (BE)
ATC code
V09IX17
ATC class
PSMA-1007 18F
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Psma-1007 18f in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All psma-1007 18f products

Authorised across Europe · EMA

The same active substance is authorised in 13 EEA countries. Names it is sold under:

  • Austria · Radelumin
  • Germany · Radelumin
  • Spain · Radelumin
  • France · Radelumin
  • Greece · Próstalumin
  • Iceland · Axumin
  • Italy · Radelumin
  • Liechtenstein · Axumin
  • Luxembourg · Radelumin
  • Netherlands · Radelumin
  • Norway · Axumin
  • Poland · Radelumin
  • Portugal · Radelumin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ba9aa772-887c-4eed-bab2-730cb0960bdd
GET /v1/drugs/ba9aa772-887c-4eed-bab2-730cb0960bdd?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Solution for injection",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Radelumin 1300 MBq/ml",
  "name_fr": "Radelumin 1300 MBq/ml",
  "name_nl": "Radelumin 1300 MBq/ml",
  "amp_code": "SAM661416-00",
  "strengths": [
    "1300.0000",
    "0.4300",
    "0.0380",
    "0.0750",
    "0.0750",
    "10.0000",
    "0.0000",
    "3.0000"
  ],
  "pack_count": 3,
  "substances": [
    "(3S,10S,14S)-1-[4-[[(2S)-4-carboxy-2-[(2S)-4-carboxy-2-(6-[18F]fluoropyridin-3-amido)butanamido]butanamido]methyl]phenyl]-3-[(naphthalen-2-yl)methyl]-1,4,12-trioxo-2,5,11,13-tetraazahexadecane-10,14,16-tricarboxylic acid",
    "Disodium Phosphate",
    "Anhydrous Ethanol",
    "Potassium Chloride",
    "Potassium Dihydrogen Phosphate",
    "Sodium Ascorbate",
    "Sodium Chloride Solution",
    "Sodium Chloride"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "PSMA-1007 (18F)",
  "authorisation_numbers": [
    "BE661417",
    "BE661416",
    "BE661418"
  ]
}

See everything about psma-1007 18f.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.